Dapagliflozin, between the zeal of the clinical studies and the challenges of the day-to-day practice

Back

HFA Premium Access

Dapagliflozin, between the zeal of the clinical studies and the challenges of the day-to-day practice

Session: ePosters in chronic heart failure - pharmacotherapy 1

Topic: Pharmacotherapy

Speaker: Doctor M. ElRefai (Basildon, GB)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Mohamed ElRefai

Basildon University Hospital, Basildon (United Kingdom of Great Britain & Northern Ireland)

0 follower

6 more presentations in this session

Evolution of inappropriate oral iron use in heart failure patients with reduced ejection fraction

Speaker: Doctor N. Chapet (Montpellier, FR)

Access

Abstract

Slides

Real-world implementation of guideline-directed treatment in advanced heart failure: single center experience

Speaker: Professor H. Sisakian (Yerevan, AM)

Access

Abstract

Slides

Flexible vs. fixed diuretic regimen in the management of advanced chronic heart failure: study protocol for a pilot randomized control trial

Speaker: Doctor A. Jiang (London, CA)

Access

Abstract

Slides

NTproBNP is not a good prognostic marker in patients with advanced heart failure on ambulatory levosimendan infusion program

Speaker: Doctor I. Fialho (Lisbon, PT)

Access

Abstract

Slides

Comparison analysis of furosemide and torasemide efficacy in 24 hours of acute heart failure initial treatment

Speaker: Doctor M. Malek-Elikowska (Poznan, PL)

Access

Abstract

Slides

Access the full session

ePosters in chronic heart failure - pharmacotherapy 1

Speakers: Doctor M. ElRefai, Doctor N. Chapet, Professor H. Sisakian, Doctor A. Jiang, Doctor I. Fialho...

Access

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources